Commerzbank set a €61.00 ($70.93) price target on Brenntag (FRA:BNR) in a research report sent to investors on Friday. The firm currently has a buy rating on the stock.

BNR has been the subject of a number of other research reports. UBS Group set a €50.00 ($58.14) price objective on shares of Brenntag and gave the company a neutral rating in a research note on Monday, August 20th. Hauck & Aufhaeuser set a €62.00 ($72.09) price objective on shares of Brenntag and gave the company a buy rating in a research note on Tuesday, July 24th. Warburg Research set a €60.00 ($69.77) price objective on shares of Brenntag and gave the company a buy rating in a research note on Wednesday, August 8th. Berenberg Bank set a €57.00 ($66.28) price objective on shares of Brenntag and gave the company a neutral rating in a research note on Monday, September 3rd. Finally, Kepler Capital Markets set a €63.00 ($73.26) price objective on shares of Brenntag and gave the company a buy rating in a research note on Wednesday, August 8th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus price target of €58.46 ($67.98).

FRA:BNR traded down €0.39 ($0.45) on Friday, reaching €47.00 ($54.65). The stock had a trading volume of 344,273 shares. Brenntag has a 12-month low of €43.06 ($50.07) and a 12-month high of €56.25 ($65.41).

Brenntag Company Profile

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Read More: Discount Rate

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.